At a glance
Ototoxicity is the impairment of hearing or balance caused by drugs or chemicals that damage cells in the cochlea or the vestibular system.
Early signs are tinnitus and high-frequency hearing loss. Vestibular involvement causes imbalance, unsteadiness when walking and oscillopsia (bouncing vision).
Tinnitus or balance symptoms in a patient on an at-risk drug must be taken seriously and reported to the treating doctor without delay.
Prevention comes first: the lowest effective dose and regular monitoring. Permanent loss is managed with hearing aids or a CI, and vestibular loss with vestibular rehabilitation.
Medical disclaimer. This content is for informational purposes only and does not replace a physician’s examination, diagnosis or treatment; it should not be used as medical advice. For your complaints or personal situation, always consult an ear, nose and throat physician and an audiologist.
If you are taking an at-risk drug such as an aminoglycoside or cisplatin and notice tinnitus, reduced hearing or a balance problem, tell the doctor managing your treatment straight away. Because these drugs are often given for a life-threatening illness, do not stop them on your own; decide together with your doctor and keep up your scheduled hearing tests.
Definition and epidemiology
Ototoxicity is loss of function caused by drugs or chemicals that damage cells in the cochlea (hearing) and the vestibular system (balance). The degree of damage depends on the drug, its dose and duration and on individual susceptibility.
Hearing loss is typically bilateral and symmetrical and affects the high frequencies first. Damage may therefore be well under way before the person notices any difficulty with everyday conversation (Ganesan et al., 2018).
The effect of some drugs is reversible (e.g. high-dose aspirin), whereas with others, such as aminoglycosides and cisplatin, the damage can be permanent.
Symptoms and signs
In cochlear involvement, tinnitus and high-frequency hearing loss are early symptoms. As the loss spreads to the speech frequencies, speech discrimination becomes harder.
In vestibular involvement, imbalance, a feeling of swaying when walking and oscillopsia (the visual world bouncing with head movement) may occur; these symptoms are worse in the dark and on uneven ground. Bilateral aminoglycoside damage can produce bilateral vestibulopathy.
Symptoms can appear during treatment or after it has ended.
Causes and risk factors
The main ototoxic drug groups are aminoglycoside antibiotics, platinum-based chemotherapy (especially cisplatin), loop diuretics and high-dose salicylates (aspirin). Some aminoglycosides (gentamicin, streptomycin) are mainly vestibulotoxic, while others (amikacin, neomycin) are mainly cochleotoxic (Rybak and Ramkumar, 2007).
Risk rises with high doses and prolonged use, renal failure, older age, concurrent noise exposure and genetic susceptibility. In carriers of the mitochondrial m.1555A>G variant, aminoglycosides can cause severe hearing loss even after a single dose (see mitochondrial hearing loss).
Combining more than one ototoxic drug, or noise exposure during the same period, can markedly increase the damage (Rybak and Ramkumar, 2007).
Audiological and clinical assessment
A baseline hearing assessment is carried out before an at-risk drug is started, and regular monitoring during and after treatment is essential (ASHA, 1994).
- High-frequency audiometry (9-20 kHz): the most sensitive method for early detection, because damage often begins in this range (ASHA, 1994).
- OAE: objectively shows early changes in cochlear outer hair cells and is especially useful in patients who cannot take part in behavioural testing.
- Pure-tone and speech audiometry: determine the degree of loss and its effect on communication.
- Vestibular tests (vHIT, VEMP, caloric): assess involvement of the balance system.
- Serial comparison: relative to baseline, a 20 dB shift at one frequency, a 10 dB shift at two adjacent frequencies, or loss of response at three consecutive frequencies where responses were previously obtained counts as significant change; it must be confirmed by retesting (ASHA, 1994).
When monitoring picks up damage early, the doctor can review the dose or the treatment protocol.
Treatment and audiological rehabilitation
The most effective approach is prevention: the lowest effective dose, regular monitoring and, where possible, alternative drugs. The decision always rests with the treating doctor, because an ototoxic drug is often being used for a life-threatening illness.
In children, sodium thiosulfate can be used in certain protocols to reduce cisplatin-induced hearing loss. In the SIOPEL 6 trial in children with standard-risk hepatoblastoma, adding sodium thiosulfate lowered the incidence of hearing loss from 63% to 33% (Brock et al., 2018). Other otoprotective approaches are still being researched.
Patients who develop a permanent loss are assessed for hearing aids, and those with profound loss for a cochlear implant. In permanent vestibular loss, vestibular rehabilitation improves balance by supporting central compensation.
Impact on quality of life and advice
Hearing and balance loss add a further burden during treatment for a serious illness and can lower quality of life. Patient-reported questionnaires are useful for tracking this impact.
Patients on an at-risk drug who notice tinnitus, reduced hearing or a balance problem should tell their doctor and keep up their scheduled hearing tests. Avoiding additional noise during this period is protective (see noise-induced hearing loss).
If you used this review, you can cite it as follows (APA 7):
Auditory Scene. (2026). Ototoxicity (Drug-Induced Inner-Ear Damage). Hearing & Balance Health Guide. https://auditoryscene.com/guncel-haberler/categories/isitme-sagligi-rehberi/ototoksisite/Permanent link: auditoryscene.com/guncel-haberler/categories/isitme-sagligi-rehberi/ototoksisite/ · Last reviewed: October 2026 · License: CC BY-NC-ND 4.0
References
- American Speech-Language-Hearing Association. (1994). Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. ASHA.
- Brock, P. R., Maibach, R., Childs, M., et al. (2018). Sodium thiosulfate for protection from cisplatin-induced hearing loss. New England Journal of Medicine, 378(25), 2376-2385.
- Ganesan, P., Schmiedge, J., Manchaiah, V., et al. (2018). Ototoxicity: A challenge in diagnosis and treatment. Journal of Audiology & Otology, 22(2), 59-68.
- Rybak, L. P., & Ramkumar, V. (2007). Ototoxicity. Kidney International, 72(8), 931-935.
Frequently asked questions
Will aspirin damage my hearing permanently?
Tinnitus and reduced hearing from high-dose aspirin depend on the dose and usually resolve when the drug is stopped. This effect is not expected at low doses. Even so, if your tinnitus persists, speak to your doctor.
Could my balance system be affected while my hearing test is normal?
Yes. The hearing and balance structures can be affected to different degrees; the balance system may be damaged while hearing is normal, or the other way round. That is why both hearing and balance tests are carried out when needed in patients on at-risk drugs.
I’m on chemotherapy; how do I protect my hearing?
The most important step is regular hearing monitoring: a baseline test before treatment and checks during and after it. Damage can then be detected early and your doctor can review the treatment plan. Avoiding extra noise during this time also helps.
Can I refuse to take an ototoxic drug?
These drugs are often essential for treating serious and life-threatening illnesses, so the decision should be made together with your treating doctor. If you share your concerns about your hearing, your doctor can consider monitoring options and alternatives.
Is there a solution if I have permanent hearing loss?
Yes. Hearing aids work well for permanent loss, and cochlear implants for profound loss. If balance problems persist, vestibular rehabilitation exercises can markedly improve balance.
Scales that can be used to monitor hearing handicap and balance impact:
Auditory Scene
